Helping ViiV Healthcare to improve quality of care for people living with HIV
The global pharmaceutical company, ViiV Healthcare, commissioned us to co-develop an initiative to improve quality of care for people living with HIV (PLHIV).
The resulting Positive Pathways is an ongoing, transformational programme to share current practices in HIV care within and across countries. This unprecedented step in the field of HIV builds on ViiV’s commitment to ensure PLHIV are optimally diagnosed, fully engaged in care and able to achieve successful treatment outcomes, whilst supporting UNAID’s ambitious 90-90-901 HIV treatment target.
Our UK Healthcare and Life Sciences team helped design the programme, conducting primary research with some of the most renowned HIV centres globally and assembling an advisory board of medical experts to review and prioritise findings.
By identifying and analysing current evidence-based approaches to care and sharing them worldwide, we are helping PLHIV lead better quality lives.
We deliver the results that matter.
1. UNAID’s 90-90-90 HIV treatment target:
90% of people living with HIV diagnosed by 2020.
90% of diagnosed people on antiretroviral treatment by 2020.
90% of people on treatment with a fully suppressed viral load by 2020.
© 2020 KPMG LLP, a UK limited liability partnership, and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative, a Swiss entity. All rights reserved.
KPMG International Cooperative (“KPMG International”) is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.